Cooley Deepens Corporate Group with Partner Addition in New York
New York – July 14, 2015 – Cooley is further bolstering its New York corporate practice with the addition of partner Joshua Kaufman. Kaufman joins Cooley from the New York office of Skadden, Arps, Slate, Meagher & Flom LLP. As a member of the business & finance practice, he will advise on capital markets and other corporate work.
A former Lehman Brothers investment banker, Kaufman focuses his legal practice on equity and debt capital markets work, representing US and foreign private issuers as well as underwriters across a wide array of complex transactions. He also advises public companies on other significant transactions and provides counsel on matters of corporate law and governance, federal securities law, public reporting requirements and exchange regulations.
"We're continuing to experience record levels of activity across our public companies, M&A and capital markets practices," said Fred Muto, chair of Cooley's business department. "Josh's experience in these key areas will be an asset to our clients engaged in major transactions and offerings."
"Cooley's momentum in the US and globally is not going unnoticed, particularly by the investment banks that it represents in tech and life sciences transactions," Kaufman said. "This is a timely opportunity for me to join Cooley to help further deepen the firm's leading corporate group."
Kaufman received his BA from Harvard University and his JD and MBA from Columbia University.
For the second consecutive year, Cooley had a record breaking year handling capital markets transactions. In 2014, the firm advised on 100 completed equity offerings, including 50 initial public offerings. Cooley advised more issuers on IPOs than any other firm in the US. According to IPO Vital Signs, Cooley was the number one firm handling technology and life sciences IPOs in 2013 and 2014, as well as venture-backed company IPOs across all industries. The firm advised on 27% of all venture-backed technology IPOs and 43% of all venture-backed life sciences IPOs in 2014.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 850 lawyers across 12 offices in the United States, China and Europe.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.